CIK 0001427570
- Non-accelerated filer
- Smaller reporting company
- Emerging growth company
Vyome Holdings, Inc
Sign in to watch- Ticker
- HIND
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- Phone
- +1 949-429-6680
- Business address
- 1001 CALLE AMANECER, SAN CLEMENTE, CA, 92673
- Former names
- ReShape Lifesciences Inc., OBALON THERAPEUTICS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 1 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2018-01-29 | VandenBerg Amy VP of Reg. and Clin. Affairs | Option exercise | +1,541 | $1.31 | $2K | 6,650 |
| 2018-01-29 | VandenBerg Amy VP of Reg. and Clin. Affairs | Option exercise · Employee Stock Option (right to buy) | −4,022 | 0 | ||
| 2018-01-29 | VandenBerg Amy VP of Reg. and Clin. Affairs | Option exercise · Employee Stock Option (right to buy) | −1,087 | 0 | ||
| 2018-01-29 | VandenBerg Amy VP of Reg. and Clin. Affairs | Option exercise · Employee Stock Option (right to buy) | −1,541 | 0 | ||
| 2018-01-02 | Metzner Lisa VP of Marketing | Grant or award · Stock Option (Right to Buy) | +60,000 | 60,000 | ||
| 2018-01-02 | Rasdal Andrew P President & CEO | Grant or award · Stock Option (Right to Buy) | +300,000 | 300,000 | ||
| 2018-01-02 | Norwood Matthew VP of Sales | Grant or award · Stock Option (Right to Buy) | +50,000 | 50,000 | ||
| 2018-01-02 | Young Donald R VP of Quality Assurance | Grant or award · Stock Option (Right to Buy) | +50,000 | 50,000 | ||
| 2018-01-02 | Hussainy Nooshin VP of Finance | Grant or award · Stock Option (Right to Buy) | +50,000 | 50,000 | ||
| 2018-01-02 | Plovanic William J. Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +100,000 | 100,000 | ||
| 2018-01-02 | Huang Kelly Chief Operating Officer | Grant or award · Stock Option (Right to Buy) | +80,000 | 80,000 | ||
| 2018-01-02 | Drake Neil VP Research and Development | Grant or award · Stock Option (Right to Buy) | +35,000 | 35,000 | ||
| 2018-01-02 | Brister Mark Chief Technology Officer | Grant or award | +65,000 | 65,000 | ||
| 2018-01-02 | VandenBerg Amy VP of Reg. and Clin. Affairs | Grant or award | +60,000 | 60,000 | ||
| 2017-10-31 | Hussainy Nooshin VP of Finance | Grant or award | +502 | $7.17 | $4K | 58,545 |
| 2017-10-31 | Rasdal Andrew P President & CEO | Grant or award | +808 | $7.17 | $6K | 454,071 |
| 2017-10-31 | Johnson Steven Ernest VP of Operations | Grant or award | +942 | $7.17 | $7K | 1,689 |
| 2017-10-31 | Drake Neil VP Research and Development | Grant or award | +1,743 | $7.17 | $12K | 7,924 |
| 2017-10-31 | Brister Mark Chief Technology Officer | Grant or award | +1,860 | $7.17 | $13K | 163,870 |
| 2017-09-06 | Huang Kelly Chief Operating Officer | Grant or award · Stock Option (Right to Buy) | +269,230 | 269,230 |
Page 13 of 17 · 322 trades